ClinicalTrials.govpublic full text
Next Generation T-cell Vaccine Against Coronavirus Disease (COVID-19)
coronavirus, sars-cov-2 infection, covid-19, sars-cov-2, t-cell priming, covid vaccine, nanoparticle, t cell, cellular immunity, t-cell vaccine, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 832105
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.